These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1048 related articles for article (PubMed ID: 1537468)
1. Cytochrome P450 isozymes catalyzing 4-hydroxylation of parkinsonism-related compound 1,2,3,4-tetrahydroisoquinoline in rat liver microsomes. Suzuki T; Fujita S; Narimatsu S; Masubuchi Y; Tachibana M; Ohta S; Hirobe M FASEB J; 1992 Jan; 6(2):771-6. PubMed ID: 1537468 [TBL] [Abstract][Full Text] [Related]
2. Purification and characterization of a cytochrome P-450 isozyme catalyzing bunitrolol 4-hydroxylation in liver microsomes of male rats. Suzuki T; Narimatsu S; Fujita S; Masubuchi Y; Umeda S; Imaoka S; Funae Y Drug Metab Dispos; 1992; 20(3):367-73. PubMed ID: 1355709 [TBL] [Abstract][Full Text] [Related]
3. Induction of liver microsomal cytochrome P450 in cynomolgus monkeys. Bullock P; Pearce R; Draper A; Podval J; Bracken W; Veltman J; Thomas P; Parkinson A Drug Metab Dispos; 1995 Jul; 23(7):736-48. PubMed ID: 7587963 [TBL] [Abstract][Full Text] [Related]
4. Regioselective contribution of the cytochrome P-450 2D subfamily to propranolol metabolism in rat liver microsomes. Masubuchi Y; Kagimoto N; Narimatsu S; Fujita S; Suzuki T Drug Metab Dispos; 1993; 21(6):1012-6. PubMed ID: 7905378 [TBL] [Abstract][Full Text] [Related]
5. Cytochrome P450 isozymes involved in propranolol metabolism in human liver microsomes. The role of CYP2D6 as ring-hydroxylase and CYP1A2 as N-desisopropylase. Masubuchi Y; Hosokawa S; Horie T; Suzuki T; Ohmori S; Kitada M; Narimatsu S Drug Metab Dispos; 1994; 22(6):909-15. PubMed ID: 7895609 [TBL] [Abstract][Full Text] [Related]
6. Catalysis of the oxidation of steroid and stilbene estrogens to estrogen quinone metabolites by the beta-naphthoflavone-inducible cytochrome P450 IA family. Roy D; Bernhardt A; Strobel HW; Liehr JG Arch Biochem Biophys; 1992 Aug; 296(2):450-6. PubMed ID: 1632637 [TBL] [Abstract][Full Text] [Related]
7. Purification and characterization of a dog cytochrome P450 isozyme belonging to the CYP2D subfamily and development of its antipeptide antibody. Nakamura A; Yamamoto Y; Tasaki T; Sugimoto C; Masuda M; Kazusaka A; Fujita S Drug Metab Dispos; 1995 Nov; 23(11):1268-73. PubMed ID: 8591729 [TBL] [Abstract][Full Text] [Related]
8. Tolbutamide hydroxylation by human, rabbit and rat liver microsomes and by purified forms of cytochrome P-450. Veronese ME; McManus ME; Laupattarakasem P; Miners JO; Birkett DJ Drug Metab Dispos; 1990; 18(3):356-61. PubMed ID: 1974199 [TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibody-directed characterization of rat hepatic P450 catalyzing the omega-1 and omega-2 hydroxylation of prostaglandins. Holm KA; Park SS; Gelboin HV; Kupfer D Arch Biochem Biophys; 1989 Mar; 269(2):664-77. PubMed ID: 2919889 [TBL] [Abstract][Full Text] [Related]
10. Strain differences in CYP3A-mediated C-8 hydroxylation (1,3,7-trimethyluric acid formation) of caffeine in Wistar and Dark Agouti rats. Rapid metabolism of caffeine in debrisoquine poor metabolizer model rats. Morita K; Maeda Y; Masuda M; Kazusaka A; Imaoka S; Funae Y; Fujita S Biochem Pharmacol; 1998 May; 55(9):1405-11. PubMed ID: 10076532 [TBL] [Abstract][Full Text] [Related]
11. Metabolite complex formation of orphenadrine with cytochrome P450. Involvement of CYP2C11 and CYP3A isozymes. Roos PH; Mahnke A Biochem Pharmacol; 1996 Jul; 52(1):73-84. PubMed ID: 8678911 [TBL] [Abstract][Full Text] [Related]
12. Mouse liver phenobarbital-inducible P450 system: purification, characterization, and differential inducibility of four cytochrome P450 isozymes from D2 mouse. Honkakoski P; Lang MA Arch Biochem Biophys; 1989 Aug; 273(1):42-57. PubMed ID: 2502947 [TBL] [Abstract][Full Text] [Related]
13. Microsomal oxidation of N,N-diethylformamide and its effect on P450-dependent monooxygenases in rat liver. Amato G; Longo V; Mazzaccaro A; Gervasi PG Chem Res Toxicol; 1996; 9(5):882-90. PubMed ID: 8828925 [TBL] [Abstract][Full Text] [Related]
14. Activation of propranolol and irreversible binding to rat liver microsomes: strain differences and effects of inhibitors. Masubuchi Y; Narimatsu S; Suzuki T Biochem Pharmacol; 1992 Feb; 43(3):635-7. PubMed ID: 1540217 [TBL] [Abstract][Full Text] [Related]
15. Cytochrome P450 enzymes involved in the enhancement of propranolol N-desisopropylation after repeated administration of propranolol in rats. Narimatsu S; Mochida M; Matsumoto T; Masubuchi Y; Horie T; Nagata K; Funae Y; Cho AK; Suzuki T Chem Biol Interact; 1996 Sep; 101(3):207-24. PubMed ID: 8870689 [TBL] [Abstract][Full Text] [Related]
16. Comparison of cytochrome P450 isoenzyme profiles in rat liver and hepatocyte cultures. The effects of model inducers on apoproteins and biotransformation activities. Wortelboer HM; de Kruif CA; van Iersel AA; Falke HE; Noordhoek J; Blaauboer BJ Biochem Pharmacol; 1991 Jul; 42(2):381-90. PubMed ID: 1859452 [TBL] [Abstract][Full Text] [Related]
19. Cytochrome P450 isozymes involved in aromatic hydroxylation and side-chain N-desisopropylation of alprenolol in rat liver microsomes. Narimatsu S; Tachibana M; Masubuchi Y; Imaoka S; Funae Y; Suzuki T Biol Pharm Bull; 1995 Aug; 18(8):1060-5. PubMed ID: 8535396 [TBL] [Abstract][Full Text] [Related]
20. Identification of CYP4A11 as the major lauric acid omega-hydroxylase in human liver microsomes. Powell PK; Wolf I; Lasker JM Arch Biochem Biophys; 1996 Nov; 335(1):219-26. PubMed ID: 8914854 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]